Netherlands· NL-f5595c3960a6
Danaparoid natrium Viatris, 750 anti-Xa eenheden/0,6 ml, oplossing voor injectie/infusie
A danaparoid product containing danaparoid natrium, registered in Netherlands by Viatris Limited. The same ATC class is registered in 9 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Danaparoid is registered in 9 of 19 countries.
Countries holding a registration under ATC B01AB09 (danaparoid), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 4 of them publish a price we can compare per daily dose
Danaparoid · ATC B01AB09
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Switzerlandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DANAPAROID NATRIUM
- Manufacturer
- Viatris Limited
- Country
- Netherlands (NL)
- ATC code
- B01AB09
- ATC class
- Danaparoid
- Defined daily dose
- 1.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id126861
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
145 interactions on record for danaparoid.
Graded by severity as the source publishes them — 94 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Danaparoid · interactions on record
145 records
- 94 severe
- 51 moderate
Most severe, free to view
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Danaparoid in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDanaparoid sodium 750units/0.6ml solution for injection ampoulesAlliance Healthcare (Distribution) Ltd
- SwitzerlandOrgaran, InjektionslösungViatris Pharma GmbH
- SpainTRALEUSIN 750 U ANTI-XA/0,6 ML SOLUCION INYECTABLE Y PARA PERFUSIONViatris Limited
- FranceORGARAN 750 U.I. anti Xa/0,6 ml, solution injectable en ampouleVIATRIS SANTE
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/edd4abe6-8aca-4a92-bbd8-1597461399f5 GET /v1/drugs/edd4abe6-8aca-4a92-bbd8-1597461399f5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie of infusie",
"route": "Subcutaan gebruik, Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h126861_smpc.pdf",
"strength": null,
"atc_label": "Danaparoid",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg126861",
"excipients": [
"NATRIUMCHLORIDE",
"NATRIUMSULFIET 0-WATER (E 221)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"DANAPAROID NATRIUM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h126861.pdf",
"authorised_at": "2021/12/01",
"procedure_number": "NL/H/5208/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "126861",
"additional_monitoring": "N"
}See everything about danaparoid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.